Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03369847 · ClinicalTrials.gov registry record · Phase 4
Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge
A Phase 4 study, sponsored by New York City Health and Hospitals Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 43
- Enrollment target
NCT03369847: Completed Phase 4 study, sponsored by New York City Health and Hospitals Corporation.
NCT03369847 is a Phase 4 study that has completed, run by New York City Health and Hospitals Corporation. The registered enrollment target is 43 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03369847, a Phase 4 study, has completed, sponsored by New York City Health and Hospitals Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 43 participants
- Enrollment target
Study Summary
This study evaluates the initiation of inhaled corticosteroids upon discharge from the pediatric emergency room in children under 18 presenting with asthma exacerbation. Half of the patients will receive a prescription for inhaled corticosteroids in addition to standard care, and half of the patients will receive standard card alone.
Primary Outcome
Emergency department/urgent care visit or unscheduled primary care doctor visit for asthma symptoms
Interventions
- DRUG budesonide, beclomethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2017-09-10 |
| Est. Completion | 2019-06-30 |
| Phase | Phase 4 |
What the finished NCT03369847 record still lists
NCT03369847 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which budesonide, beclomethasone is the first listed.
NCT03369847 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03369847 about?
NCT03369847 is a clinical study titled "Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge". This study evaluates the initiation of inhaled corticosteroids upon discharge from the pediatric emergency room in children under 18 presenting with asthma exacerbation. Half of the patients will receive a prescription for inhaled corticosteroids in addition to standard care, and half of the patient...
What is the current status of trial NCT03369847?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 43 participants. The study started on 2017-09-10. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT03369847?
The interventions under investigation include: budesonide, beclomethasone (DRUG).
Who is sponsoring clinical trial NCT03369847?
This trial is sponsored by New York City Health and Hospitals Corporation, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03369847's enrollment target sits among peer trials
43 1371st of 2000 higher than 621 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI